All IndicationsInfectious Disease
🦠
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)
1
Companies
1
Drug Programs
1
Phase 3
0
Upcoming PDUFAs
Competitors
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| AVIR Atea Pharmaceuticals, Inc. | Bemnifosbuvir (BEM) | Phase 3 | — | — | — |
Development Stage Distribution
Phase 3
1
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not Financial Advice
All predictions are probabilistic and based on historical data. Past performance does not guarantee future results. Consult a qualified financial advisor.